Bruker (BRKR) Tops Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts BRKR Hot Sheet
Price: $61.21 --0%
EPS Growth %: -6.7%
Financial Fact:
Total cost of revenue: 208.7M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -6.7%
Financial Fact:
Total cost of revenue: 208.7M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Bruker (NASDAQ: BRKR) reported Q1 EPS of $0.49, $0.07 better than the analyst estimate of $0.42. Revenue for the quarter came in at $595 million versus the consensus estimate of $572.57 million.
GUIDANCE:
Bruker sees FY2022 EPS of $2.29-$2.33, versus the consensus of $2.29.
For earnings history and earnings-related data on Bruker (BRKR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Oppenheimer Starts Collegium Pharmaceutical (COLL) at Outperform
- Oppenheimer Starts Teva Pharma (TEVA) at Outperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
